Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Intelligent Artificial Intelligence: Present Considerations and Future Implications of Machine Learning Applied to Electrocardiogram Interpretation.

Kao DP.

Circ Cardiovasc Qual Outcomes. 2019 Sep;12(9):e006021. doi: 10.1161/CIRCOUTCOMES.119.006021. Epub 2019 Sep 5. No abstract available.

PMID:
31525077
2.

Sequential analysis of myocardial gene expression with phenotypic change: Use of cross-platform concordance to strengthen biologic relevance.

Toni LS, Carroll IA, Jones KL, Schwisow JA, Minobe WA, Rodriguez EM, Altman NL, Lowes BD, Gilbert EM, Buttrick PM, Kao DP, Bristow MR.

PLoS One. 2019 Aug 30;14(8):e0221519. doi: 10.1371/journal.pone.0221519. eCollection 2019.

3.

Design of a "Lean" Case Report Form for Heart Failure Therapeutic Development.

Psotka MA, Fiuzat M, Carson PE, Kao DP, Cerkvenik J, Schaber DE, Verta P, Kazmierski RT, Shinnar M, Stockbridge N, Unger EF, Zuckerman B, Butler J, Felker GM, Konstam MA, Lindenfeld J, Solomon SD, Teerlink JR, O'Connor CM, Abraham WT.

JACC Heart Fail. 2019 Aug 7. pii: S2213-1779(19)30542-6. doi: 10.1016/j.jchf.2019.07.001. [Epub ahead of print] Review.

4.

Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial.

Piccini JP, Abraham WT, Dufton C, Carroll IA, Healey JS, van Veldhuisen DJ, Sauer WH, Anand IS, White M, Wilton SB, Aleong R, Rienstra M, Krueger SK, Ayala-Paredes F, Khaykin Y, Merkely B, Miloradović V, Wranicz JK, Ilkhanoff L, Ziegler PD, Davis G, Emery LL, Marshall D, Kao DP, Bristow MR, Connolly SJ; GENETIC-AF Trial Investigators.

JACC Heart Fail. 2019 Jul;7(7):586-598. doi: 10.1016/j.jchf.2019.04.004. Epub 2019 Apr 29.

PMID:
31042551
5.

Clinician preferences for computerised clinical decision support for medications in primary care: a focus group study.

Trinkley KE, Blakeslee WW, Matlock DD, Kao DP, Van Matre AG, Harrison R, Larson CL, Kostman N, Nelson JA, Lin CT, Malone DC.

BMJ Health Care Inform. 2019 Apr;26(1):0. doi: 10.1136/bmjhci-2019-000015.

6.

Sex Differences in Outcomes and Responses to Spironolactone in Heart Failure With Preserved Ejection Fraction: A Secondary Analysis of TOPCAT Trial.

Merrill M, Sweitzer NK, Lindenfeld J, Kao DP.

JACC Heart Fail. 2019 Mar;7(3):228-238. doi: 10.1016/j.jchf.2019.01.003.

PMID:
30819379
7.

Marijuana use and short-term outcomes in patients hospitalized for acute myocardial infarction.

Johnson-Sasso CP, Tompkins C, Kao DP, Walker LA.

PLoS One. 2018 Jul 11;13(7):e0199705. doi: 10.1371/journal.pone.0199705. eCollection 2018.

8.

Short-term risk of cardiovascular readmission following a hypertensive disorder of pregnancy.

Jarvie JL, Metz TD, Davis MB, Ehrig JC, Kao DP.

Heart. 2018 Jul;104(14):1187-1194. doi: 10.1136/heartjnl-2017-312299. Epub 2018 Jan 11.

PMID:
29326108
9.

Histamine H2 Receptor Polymorphisms, Myocardial Transcripts, and Heart Failure (from the Multi-Ethnic Study of Atherosclerosis and Beta-Blocker Effect on Remodeling and Gene Expression Trial).

Leary PJ, Kronmal RA, Bluemke DA, Buttrick PM, Jones KL, Kao DP, Kawut SM, Krieger EV, Lima JA, Minobe W, Ralph DD, Tedford RJ, Weiss NS, Bristow MR.

Am J Cardiol. 2018 Jan 15;121(2):256-261. doi: 10.1016/j.amjcard.2017.10.016. Epub 2017 Oct 20.

10.

Structural and Functional Phenotyping of the Failing Heart: Is the Left Ventricular Ejection Fraction Obsolete?

Bristow MR, Kao DP, Breathett KK, Altman NL, Gorcsan J 3rd, Gill EA, Lowes BD, Gilbert EM, Quaife RA, Mann DL.

JACC Heart Fail. 2017 Nov;5(11):772-781. doi: 10.1016/j.jchf.2017.09.009. Review.

11.

The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart Association.

Maddox TM, Albert NM, Borden WB, Curtis LH, Ferguson TB Jr, Kao DP, Marcus GM, Peterson ED, Redberg R, Rumsfeld JS, Shah ND, Tcheng JE; American Heart Association Council on Quality of Care and Outcomes Research; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; and Stroke Council.

Circulation. 2017 Apr 4;135(14):e826-e857. doi: 10.1161/CIR.0000000000000480. Epub 2017 Mar 2. Review.

PMID:
28254835
12.

Myocardial microRNAs associated with reverse remodeling in human heart failure.

Sucharov CC, Kao DP, Port JD, Karimpour-Fard A, Quaife RA, Minobe W, Nunley K, Lowes BD, Gilbert EM, Bristow MR.

JCI Insight. 2017 Jan 26;2(2):e89169. doi: 10.1172/jci.insight.89169.

13.

Phenotype-Specific Association of Single-Nucleotide Polymorphisms with Heart Failure and Preserved Ejection Fraction: a Genome-Wide Association Analysis of the Cardiovascular Health Study.

Kao DP, Stevens LM, Hinterberg MA, Görg C.

J Cardiovasc Transl Res. 2017 Jun;10(3):285-294. doi: 10.1007/s12265-017-9729-1. Epub 2017 Jan 19.

14.

Sex differences and in-hospital outcomes in patients undergoing mechanical circulatory support implantation.

McIlvennan CK, Lindenfeld J, Kao DP.

J Heart Lung Transplant. 2017 Jan;36(1):82-90. doi: 10.1016/j.healun.2016.08.013. Epub 2016 Aug 20.

PMID:
27773454
15.

Sex-related differences in age-associated downregulation of human ventricular myocardial β1-adrenergic receptors.

Lindenfeld J, Cleveland JC Jr, Kao DP, White M, Wichman S, Bristow JC, Peterson V, Rodegheri-Brito J, Korst A, Blain-Nelson P, Sederberg J, Hunt SA, Gilbert EM, Ambardekar AV, Minobe W, Port JD, Bristow MR.

J Heart Lung Transplant. 2016 Mar;35(3):352-361. doi: 10.1016/j.healun.2015.10.021. Epub 2015 Oct 19.

PMID:
26970472
16.

Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.

Kao DP, Lewsey JD, Anand IS, Massie BM, Zile MR, Carson PE, McKelvie RS, Komajda M, McMurray JJ, Lindenfeld J.

Eur J Heart Fail. 2015 Sep;17(9):925-35. doi: 10.1002/ejhf.327. Epub 2015 Aug 6.

17.

Impact of a Telehealth and Care Management Program on All-Cause Mortality and Healthcare Utilization in Patients with Heart Failure.

Kao DP, Lindenfeld J, Macaulay D, Birnbaum HG, Jarvis JL, Desai US, Page RL 2nd.

Telemed J E Health. 2016 Jan;22(1):2-11. doi: 10.1089/tmj.2015.0007. Epub 2015 Jul 28.

18.

Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.

Kao DP, Haigney MC, Mehler PS, Krantz MJ.

Addiction. 2015 Sep;110(9):1468-75. doi: 10.1111/add.13013.

19.

Visual analysis of biological data-knowledge networks.

Vehlow C, Kao DP, Bristow MR, Hunter LE, Weiskopf D, Görg C.

BMC Bioinformatics. 2015 Apr 29;16:135. doi: 10.1186/s12859-015-0550-z.

20.

Safety of ventricular tachycardia ablation in clinical practice: findings from 9699 hospital discharge records.

Katz DF, Turakhia MP, Sauer WH, Tzou WS, Heath RR, Zipse MM, Aleong RG, Varosy PD, Kao DP.

Circ Arrhythm Electrophysiol. 2015 Apr;8(2):362-70. doi: 10.1161/CIRCEP.114.002336. Epub 2015 Feb 15.

PMID:
25688143
21.

Therapeutic Molecular Phenotype of β-Blocker-Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy.

Kao DP, Lowes BD, Gilbert EM, Minobe W, Epperson LE, Meyer LK, Ferguson DA, Volkman AK, Zolty R, Borg CD, Quaife RA, Bristow MR.

Circ Cardiovasc Genet. 2015 Apr;8(2):270-83. doi: 10.1161/CIRCGENETICS.114.000767. Epub 2015 Jan 30.

PMID:
25637602
22.

Peax: interactive visual analysis and exploration of complex clinical phenotype and gene expression association.

Hinterberg MA, Kao DP, Bristow MR, Hunter LE, Port JD, Görg C.

Pac Symp Biocomput. 2015:419-30.

23.
24.

Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.

Kao DP, Davis G, Aleong R, O'Connor CM, Fiuzat M, Carson PE, Anand IS, Plehn JF, Gottlieb SS, Silver MA, Lindenfeld J, Miller AB, White M, Murphy GA, Sauer W, Bristow MR.

Eur J Heart Fail. 2013 Mar;15(3):324-33. doi: 10.1093/eurjhf/hfs181. Epub 2012 Dec 7.

25.

A personalized BEST: characterization of latent clinical classes of nonischemic heart failure that predict outcomes and response to bucindolol.

Kao DP, Wagner BD, Robertson AD, Bristow MR, Lowes BD.

PLoS One. 2012;7(11):e48184. doi: 10.1371/journal.pone.0048184. Epub 2012 Nov 7.

26.

Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting.

Kao DP, Hiatt WR, Krantz MJ.

Pharmacotherapy. 2012 Aug;32(8):767-71. doi: 10.1002/j.1875-9114.2012.01118.x. Epub 2012 Jun 28.

27.

Consequences of federal patient transfer regulations: effect of the 2003 EMTALA revision on a tertiary referral center and evidence of possible misuse.

Kao DP, Martin MH, Das AK, Ruoss SJ.

Arch Intern Med. 2012 Jun 11;172(11):891-2. doi: 10.1001/archinternmed.2012.1290. No abstract available.

28.
29.

Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally?

Yoon GJ, Telli ML, Kao DP, Matsuda KY, Carlson RW, Witteles RM.

J Am Coll Cardiol. 2010 Nov 9;56(20):1644-50. doi: 10.1016/j.jacc.2010.07.023.

30.

Rosiglitazone increases myocardial glucose metabolism in insulin-resistant cardiomyopathy.

Kao DP, Witteles RM, Quon A, Wu JC, Gambhir SS, Fowler MB.

J Am Coll Cardiol. 2010 Mar 2;55(9):926-7. doi: 10.1016/j.jacc.2009.08.085. No abstract available.

31.

What can we learn from drug marketing efficiency?

Kao DP.

BMJ. 2008 Dec 2;337:a2591. doi: 10.1136/bmj.a2591. No abstract available.

32.

Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use.

Kao DP, Kohrt HE, Kugler J.

Diabet Med. 2008 Oct;25(10):1229-30. doi: 10.1111/j.1464-5491.2008.02536.x.

Supplemental Content

Support Center